Annual Accounts Payable
$311.60 K
-$15.90 K-4.85%
December 31, 2023
Summary
- As of February 7, 2025, PCSA annual accounts payable is $311.60 thousand, with the most recent change of -$15.90 thousand (-4.85%) on December 31, 2023.
- During the last 3 years, PCSA annual accounts payable has fallen by -$9100.00 (-2.84%).
- PCSA annual accounts payable is now -4.85% below its all-time high of $327.50 thousand, reached on December 31, 2022.
Performance
PCSA Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$711.70 K
-$241.40 K-25.33%
September 30, 2024
Summary
- As of February 7, 2025, PCSA quarterly accounts payable is $711.70 thousand, with the most recent change of -$241.40 thousand (-25.33%) on September 30, 2024.
- Over the past year, PCSA quarterly accounts payable has increased by +$256.30 thousand (+56.28%).
- PCSA quarterly accounts payable is now -25.33% below its all-time high of $953.10 thousand, reached on June 30, 2024.
Performance
PCSA Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
PCSA Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.8% | +56.3% |
| 3 y3 years | -2.8% | +117.3% |
| 5 y5 years | +6.7% | +117.3% |
PCSA Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -4.8% | +42.4% | -25.3% | +225.1% |
| 5 y | 5-year | -4.8% | +312.2% | -25.3% | +869.6% |
| alltime | all time | -4.8% | -100.0% | -25.3% | +1303.8% |
Processa Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $711.70 K(-25.3%) |
| Jun 2024 | - | $953.10 K(+109.3%) |
| Mar 2024 | - | $455.40 K(+46.1%) |
| Dec 2023 | $311.60 K(-4.9%) | $311.60 K(-10.0%) |
| Sep 2023 | - | $346.30 K(+44.9%) |
| Jun 2023 | - | $239.00 K(-24.5%) |
| Mar 2023 | - | $316.70 K(-3.3%) |
| Dec 2022 | $327.50 K(+49.6%) | $327.50 K(+5.3%) |
| Sep 2022 | - | $311.10 K(-52.0%) |
| Jun 2022 | - | $648.10 K(+105.0%) |
| Mar 2022 | - | $316.10 K(+44.4%) |
| Dec 2021 | $218.90 K(-31.7%) | $218.90 K(-38.3%) |
| Sep 2021 | - | $355.00 K(+23.3%) |
| Jun 2021 | - | $287.90 K(+62.7%) |
| Mar 2021 | - | $177.00 K(-44.8%) |
| Dec 2020 | $320.70 K(+324.2%) | $320.70 K(-25.0%) |
| Sep 2020 | - | $427.50 K(+482.4%) |
| Jun 2020 | - | $73.40 K(-21.2%) |
| Mar 2020 | - | $93.20 K(+23.3%) |
| Dec 2019 | $75.60 K(-74.1%) | $75.60 K(+16.5%) |
| Sep 2019 | - | $64.90 K(-54.7%) |
| Jun 2019 | - | $143.40 K(-49.3%) |
| Mar 2019 | - | $283.10 K(-3.1%) |
| Dec 2018 | $292.10 K | $292.10 K(+265.1%) |
| Sep 2018 | - | $80.00 K(-68.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $251.40 K(+139.7%) |
| Mar 2018 | - | $104.90 K(+106.9%) |
| Dec 2017 | $50.70 K(-69.5%) | $50.70 K(-47.0%) |
| Sep 2017 | - | $95.60 K(+4.8%) |
| Jun 2017 | - | $91.20 K(-49.1%) |
| Mar 2017 | - | $179.30 K(+7.9%) |
| Dec 2016 | $166.20 K(+4.4%) | $166.20 K(-2.6%) |
| Sep 2016 | - | $170.70 K(-1.8%) |
| Jun 2016 | - | $173.90 K(+2.7%) |
| Mar 2016 | - | $169.30 K(+6.3%) |
| Dec 2015 | $159.20 K(+3.4%) | $159.20 K(-16.5%) |
| Sep 2015 | - | $190.70 K(-12.8%) |
| Jun 2015 | - | $218.80 K(+23.1%) |
| Mar 2015 | - | $177.70 K(+15.5%) |
| Dec 2014 | $153.90 K(+99.9%) | $153.90 K(+6.4%) |
| Sep 2014 | - | $144.60 K(+29.1%) |
| Jun 2014 | - | $112.00 K(+35.4%) |
| Mar 2014 | - | $82.70 K(+7.4%) |
| Dec 2013 | $77.00 K(+5.2%) | $77.00 K(-24.1%) |
| Sep 2013 | - | $101.40 K(-56.5%) |
| Jun 2013 | - | $233.30 K(+44.9%) |
| Mar 2013 | - | $161.00 K(+119.9%) |
| Dec 2012 | $73.20 K(>+9900.0%) | $73.20 K(-28.0%) |
| Sep 2012 | - | $101.70 K |
| Dec 2011 | $0.00 | - |
FAQ
- What is Processa Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Processa Pharmaceuticals?
- What is Processa Pharmaceuticals annual accounts payable year-on-year change?
- What is Processa Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Processa Pharmaceuticals?
- What is Processa Pharmaceuticals quarterly accounts payable year-on-year change?
What is Processa Pharmaceuticals annual accounts payable?
The current annual accounts payable of PCSA is $311.60 K
What is the all time high annual accounts payable for Processa Pharmaceuticals?
Processa Pharmaceuticals all-time high annual accounts payable is $327.50 K
What is Processa Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, PCSA annual accounts payable has changed by -$15.90 K (-4.85%)
What is Processa Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of PCSA is $711.70 K
What is the all time high quarterly accounts payable for Processa Pharmaceuticals?
Processa Pharmaceuticals all-time high quarterly accounts payable is $953.10 K
What is Processa Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, PCSA quarterly accounts payable has changed by +$256.30 K (+56.28%)